Brophy Wealth Management LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brophy Wealth Management LLC acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 1,500 shares of the medical equipment provider's stock, valued at approximately $737,000.

A number of other hedge funds also recently bought and sold shares of ISRG. Ridgewood Investments LLC bought a new position in Intuitive Surgical during the 2nd quarter valued at approximately $26,000. Godsey & Gibb Inc. increased its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 35 shares during the last quarter. LGT Financial Advisors LLC increased its holdings in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 54 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the third quarter worth about $33,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $38,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 450 shares of the business's stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now owns 821 shares of the company's stock, valued at $402,519.88. The trade was a 35.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the business's stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares of the company's stock, valued at approximately $3,638,990. This represents a 26.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,485 shares of company stock valued at $26,128,102 over the last quarter. Corporate insiders own 0.90% of the company's stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded down $11.55 during mid-day trading on Tuesday, reaching $538.86. 1,429,189 shares of the company were exchanged, compared to its average volume of 1,445,554. Intuitive Surgical, Inc. has a 1 year low of $309.80 and a 1 year high of $556.23. The firm has a market cap of $191.93 billion, a price-to-earnings ratio of 86.63, a P/E/G ratio of 5.41 and a beta of 1.38. The firm's 50-day simple moving average is $517.16 and its 200 day simple moving average is $475.65.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Royal Bank of Canada upped their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a research report on Friday, October 18th. Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a report on Thursday, October 17th. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. Finally, Leerink Partners increased their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $541.33.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.